ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BPCR Biopharma Credit Plc

0.87
-0.026 (-2.90%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Biopharma Credit Plc LSE:BPCR London Ordinary Share GB00BDGKMY29 ORD USD0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.026 -2.90% 0.87 0.87 0.874 0.886 0.87 0.886 4,461,524 16:35:03
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 218.17M 182.31M 0.1400 5.11 932.72M

BioPharma Credit PLC Transaction in Own Shares (5991J)

13/12/2022 6:15pm

UK Regulatory


Biopharma Credit (LSE:BPCR)
Historical Stock Chart


From Mar 2022 to Mar 2024

Click Here for more Biopharma Credit Charts.

TIDMBPCR

RNS Number : 5991J

BioPharma Credit PLC

13 December 2022

BioPharma Credit plc

(the "Company")

TRANSACTION IN OWN SHARES

BioPharma Credit PLC (the "Company") announces that today it has purchased the following number of its ordinary shares of US$0.01 each on the London Stock Exchange through J.P. Morgan Securities plc into treasury.

Ordinary Shares: BPCR LN

Date of purchase: 13 December 2022

Number of ordinary shares purchased: 81,690

Lowest price per share: $0.9580

Highest price per share: $0.9580

Trading venue: London Stock Exchange

Aggregate volume per date per trading venue: 81,690

Weighted average price per day per trading venue: $0.9580

Following the above transaction, the Company holds 45,628,212 of its ordinary shares in treasury and has 1,328,303,855 ordinary shares in issue (excluding treasury shares). Therefore, the total number of voting rights in the Company is 1,328,303,855. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:

BioPharma Credit plc

via Link Company Matters Limited

Company Secretary

+44 (0)1392 477 500

Buchanan

David Rydell / Mark Court / Jamie Hooper / Henry Wilson

+44 (0)20 7466 5000

biopharmacredit@buchanan.uk.com

Notes to Editors:

BioPharma Credit PLC is London's only listed specialist investor in debt from the life sciences industry and joined the LSE on 27 March 2017. The Company seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. The Company seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.

LEI: 213800AV55PYXAS7SY24

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSDXLFFLLLLFBF

(END) Dow Jones Newswires

December 13, 2022 13:15 ET (18:15 GMT)

1 Year Biopharma Credit Chart

1 Year Biopharma Credit Chart

1 Month Biopharma Credit Chart

1 Month Biopharma Credit Chart

Your Recent History

Delayed Upgrade Clock